TMC, Mumbai, BALCO Medical Centre, Raipur sign MoU to advance cancer care in India – ET HealthWorld

Mumbai: The Tata Memorial Centre (TMC), Mumbai, and Vedanta Medical Research Foundation’s flagship initiative, BALCO Medical Centre (BMC), Raipur, Chhattisgarh, have entered into a memorandum of understanding (MoU) to drive excellence in cancer care in the country. The MoU was signed between Dr RA Badwe, Director, Tata Memorial Centre, and Dr Bhawna Sirohi, Medical Director, BALCO Medical Centre, at Tata Memorial Hospital, Parel, in the presence of Jyoti Agarwal, Chairperson, BALCO Medical Centre.

As per the MoU, the BALCO Medical Centre and Tata Memorial Centre will join forces for exchange of knowledge, and enhancement of skills, capabilities and core practices. BMC will leverage TMC’s expertise and decades of experience in cancer treatment for developing best-in-class technical and medical guidelines. With this association, TMC will also empanel BMC as a referral centre for patients from Chhattisgarh, and neighbouring states. Both cancer hospitals have mutually agreed to:

1. Share best practices and evolving knowledge on cancer treatment
2. BMC will take part in the National Cancer Grid Virtual Tumour Boards to drive excellence in patient care
3. Mutually conduct and participate in continuing medical education (CME) sessions at both the locations
4. Conduct joint research or multi-centric trials

Elated with the association, Agarwal said, “Now, with this MoU, I look forward to the next phase of our growth, wherein, together, we will learn more and find new ways to serve communities better.”

Dr Sirohi, said, “It is time to spread our wings farther by collaborating with TMC for mutual learning and knowledge, including staff training, educational sessions, institutional fellowships, cross-referrals of patients and joint research, which will shape the future of cancer care in India.”

Speaking about the association with BALCO Medical Centre, Dr Badwe said, “This association will help us to collaborate with the experts from BMC for mutual exchange of knowledge and conduct cancer research jointly. Interactions such as these will also allow assessment of the viability of any new idea amongst experts in both the organisations.”